Outpatient low-dose computed tomography metrizamide myelography and evaluation of lumbar disk disease

Arthur B. Dublin, Michael H Reid

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Outpatient low-dose computed tomography metrizamide myelography (CTMM) for the evaluation of lumbar disk disease is described in 55 patients. Ten individuals (group 1) were studied using 3.5 ml of 150 mg I/ml (525 mg I total) of metrizamide. Forty-five additional patients (group 2) were examined with 5 ml of 110 mg I/ml (550 mg I total) concentration of metrizamide. Group 2 experienced less postprocedure headache (6.6%) and nausea (2.2%) than did group 1 (30% and 10%, respectively). Group 2 demonstrated a lowered rate of headache (p <.01) and showed a trend to less nausea (p <.09) than a recently published study describing full-dose lumbar myelography. In addition, CTMM in group 2 produced more uniform mixing of metrizamide than in group 1. Overall, low-dose CTMM increased accuracy and reduced morbidity, patient cost, and inconvenience as compared with routine full-dose lumbar myelography.

Original languageEnglish (US)
Pages (from-to)113-117
Number of pages5
JournalJournal of Computed Tomography
Volume8
Issue number2
DOIs
StatePublished - 1984

Fingerprint

Metrizamide
Myelography
Tomography
Outpatients
Nausea
Headache
Intervertebral disc disease
Costs
Morbidity
Costs and Cost Analysis

Keywords

  • Computed tomography, cost-effectiveness
  • Computed tomography, metrizamide enhancement
  • Spine, computed tomography

ASJC Scopus subject areas

  • Bioengineering
  • Radiology Nuclear Medicine and imaging

Cite this

Outpatient low-dose computed tomography metrizamide myelography and evaluation of lumbar disk disease. / Dublin, Arthur B.; Reid, Michael H.

In: Journal of Computed Tomography, Vol. 8, No. 2, 1984, p. 113-117.

Research output: Contribution to journalArticle

@article{ff420cd712084814a001fa5276175e5d,
title = "Outpatient low-dose computed tomography metrizamide myelography and evaluation of lumbar disk disease",
abstract = "Outpatient low-dose computed tomography metrizamide myelography (CTMM) for the evaluation of lumbar disk disease is described in 55 patients. Ten individuals (group 1) were studied using 3.5 ml of 150 mg I/ml (525 mg I total) of metrizamide. Forty-five additional patients (group 2) were examined with 5 ml of 110 mg I/ml (550 mg I total) concentration of metrizamide. Group 2 experienced less postprocedure headache (6.6{\%}) and nausea (2.2{\%}) than did group 1 (30{\%} and 10{\%}, respectively). Group 2 demonstrated a lowered rate of headache (p <.01) and showed a trend to less nausea (p <.09) than a recently published study describing full-dose lumbar myelography. In addition, CTMM in group 2 produced more uniform mixing of metrizamide than in group 1. Overall, low-dose CTMM increased accuracy and reduced morbidity, patient cost, and inconvenience as compared with routine full-dose lumbar myelography.",
keywords = "Computed tomography, cost-effectiveness, Computed tomography, metrizamide enhancement, Spine, computed tomography",
author = "Dublin, {Arthur B.} and Reid, {Michael H}",
year = "1984",
doi = "10.1016/0149-936X(84)90094-8",
language = "English (US)",
volume = "8",
pages = "113--117",
journal = "Clinical Imaging",
issn = "0899-7071",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Outpatient low-dose computed tomography metrizamide myelography and evaluation of lumbar disk disease

AU - Dublin, Arthur B.

AU - Reid, Michael H

PY - 1984

Y1 - 1984

N2 - Outpatient low-dose computed tomography metrizamide myelography (CTMM) for the evaluation of lumbar disk disease is described in 55 patients. Ten individuals (group 1) were studied using 3.5 ml of 150 mg I/ml (525 mg I total) of metrizamide. Forty-five additional patients (group 2) were examined with 5 ml of 110 mg I/ml (550 mg I total) concentration of metrizamide. Group 2 experienced less postprocedure headache (6.6%) and nausea (2.2%) than did group 1 (30% and 10%, respectively). Group 2 demonstrated a lowered rate of headache (p <.01) and showed a trend to less nausea (p <.09) than a recently published study describing full-dose lumbar myelography. In addition, CTMM in group 2 produced more uniform mixing of metrizamide than in group 1. Overall, low-dose CTMM increased accuracy and reduced morbidity, patient cost, and inconvenience as compared with routine full-dose lumbar myelography.

AB - Outpatient low-dose computed tomography metrizamide myelography (CTMM) for the evaluation of lumbar disk disease is described in 55 patients. Ten individuals (group 1) were studied using 3.5 ml of 150 mg I/ml (525 mg I total) of metrizamide. Forty-five additional patients (group 2) were examined with 5 ml of 110 mg I/ml (550 mg I total) concentration of metrizamide. Group 2 experienced less postprocedure headache (6.6%) and nausea (2.2%) than did group 1 (30% and 10%, respectively). Group 2 demonstrated a lowered rate of headache (p <.01) and showed a trend to less nausea (p <.09) than a recently published study describing full-dose lumbar myelography. In addition, CTMM in group 2 produced more uniform mixing of metrizamide than in group 1. Overall, low-dose CTMM increased accuracy and reduced morbidity, patient cost, and inconvenience as compared with routine full-dose lumbar myelography.

KW - Computed tomography, cost-effectiveness

KW - Computed tomography, metrizamide enhancement

KW - Spine, computed tomography

UR - http://www.scopus.com/inward/record.url?scp=0021191765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021191765&partnerID=8YFLogxK

U2 - 10.1016/0149-936X(84)90094-8

DO - 10.1016/0149-936X(84)90094-8

M3 - Article

C2 - 6713922

AN - SCOPUS:0021191765

VL - 8

SP - 113

EP - 117

JO - Clinical Imaging

JF - Clinical Imaging

SN - 0899-7071

IS - 2

ER -